Non-Alcoholic Steatohepatitis (NASH) Trial

Non-Alcoholic Steatohepatitis (NASH) Trial 

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:

 

  • Be between the ages if 18 and 75
  • Have had liver biopsy or be willing to undergo a liver biopsy

 Qualified participants may receive:

 

  • Compensation for time & travel
  • Study-related care at no cost

 For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or soberdier@gen1research.com

DDAR Blog

9/19/19

As you may have read, the FDA recently released a warning regarding Ranitidine a medication frequently used for heartburn.  They reported that they found low levels of a carcinogenic impurity...

Latest News

12/12/19

Non-Alcoholic Steatohepatitis (NASH) Trial 

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an...